北美的AI支援医疗影像市场

North America AI-assisted Medical Imaging Market

出版日期: 2025年09月04日 | 出版商:

Marketstrat, Inc. | 英文 54 Pages | 订单完成后即时交付

价格

简介目录图表

调查范围

国家美国，加拿大
模式CT，MRI，X光/DR，超音波，PET/核医学
临床领域肿瘤学，神经学/中风，心臟病，呼吸系统/肺，MSK/整形，一般
用途分诊→检测→重组→整合
收益的流程硬体设备，软体，服务，云端/利用费用制
最终用途医院/IDN，影像诊断中心，诊所，远隔放射线医疗，其他.(章节2，目的和范围)

研究方法

双视角方法：自上而下分析北美药品总数及各国具体比例；自下而上分析原厂安装和改造组合、平均售价区间以及各北美药品特定证据权重（FDA/加拿大卫生部）。根据节奏、报销讯号、企业采购和真实世界数据 (RWE)，按模式划分的依从性推动因素。

报告概述

发展轨迹：到 2032 年，北美市场规模将扩大至 132 亿美元（复合年增长率 30%）（摘要整理，第 10 页；表 1，第 14 页）。
沾黏余量：OEM 的 AI 将安装在 20% 的新 CT 和 15% 的新 MR 样本跑道中，包括超音波和 PET。（包装说明书定价讨论和图 3，第 18-19 页。）

推动数位成长的因素

降低报销额：得益于 CMS 的 NTAP 更新（卒中 AI）以及用于 CT-FFR、迴声失真和乳腺 AI 的新 CPT 堆栈，美国继续占主导地位，其增长速度约为加拿大的 9 倍。
企业购买力：美国大型 IDN 已获得多年的 "AI 商店" 许可证，支出扩张速度快于基本扫描的成长速度。
监管澄清：FDA 的 "预定变更控制计画" 草案允许演算法升级无需重新提交，从而缩短了更新周期并提高了平均回报率 (ARR)。
加拿大迎头赶上：单一支付州正在谨慎行事，但全国范围内的肺癌筛检试点和针对 CADTH 特异性结核病 AI 的 HTA 正在推动其应用。虽然复合年增长率低至 29%，但市场规模每三年仍翻倍。
跨国供应商：如果美国云端 AI 供应商能够证明其隐私合规性（PIPEDA/HIPAA），则更有可能赢得加拿大的竞标，从而进一步缩小差距。

报告优势

切入点/取胜之道 NAGTM 成长与成熟度矩阵、竞争资料集、监管速度与併购观察名单。（图表，第 15-18 页）。
国家策略手册：美国和加拿大 GTM 雷达、渠道/定价矩阵、客户潜力以及包含 12 个月行动提示的时间表。（美国，第 31-38 页，加拿大，第 52-54 页）。
预测深度：依国家、治疗模式、临床领域、应用、收入来源和最终用途细分，直至 2032 年。（表格请参阅第 24-30 页及第 43-51 页。）

市场摘要-美国
市场概要-美国
- 人口统计与流行病学
- 宏观经济与医疗保健支出
- 影像数量和安装基数
- 监理与报销概况
- 医疗保健服务与实践模式
- AI 市场动态（影像）
- 竞争格局
- 供应商经验教训
以临床领域划分的美国市场
以影像模式划分的美国市场
以收入来源划分的美国市场
以临床应用划分的美国市场
以最终使用机构划分的美国市场
以 AI 技术划分的美国市场
Ma Markintel 成长成熟度矩阵 - 美国和加拿大
Markintel 解采用和成长矩阵 - 美国和加拿大
Markintel 生态系协作矩阵 - 美国与加拿大
GTM 概览 - 美国

章节5-加拿大市场

市场摘要:加拿大
市场概要-加拿大
各临床领域加拿大市场
加拿大市场，各临床领域
加拿大市场，影像诊断法
加拿大市场，不同收益来源
加拿大市场，各临床用途
加拿大市场，各最终用途组织
加拿大市场，各AI技术
GTM概要- 加拿大

简介目录图表

Product Code: MINTP-M01120

Report Scope

Countries: United States, Canada
Modalities: CT, MRI, X ray/DR, Ultrasound, PET/Nuclear
Clinical Areas: Oncology, Neurology/Stroke, Cardiology, Respiratory/Lung, MSK/Ortho, General
Applications: Triage -> detection -> reconstruction -> integration
Revenue Streams: Hardware, Software, Services, Cloud/Pay per Use
End use: Hospitals/IDNs, Imaging Centers, Clinics, Teleradiology, Other. (Section 2, Objective & Scope.)

Methodology

Dual lens approach: top down reconciliation to NA totals and country splits; bottom up attach rate engine by modality with factory vs retrofit mixes, ASP bands, and NA specific evidence weights (FDA/Health Canada cadence, reimbursement signals, enterprise buying, and RWE).

Report Snapshot

Trajectory: North America expands to ~US$13.2B by 2032 (~30% CAGR) . (Executive Summary, p.10; Table 1, p.14.)
Attach rate headroom: OEM AI ships on ~20% of new CT and ~15% of new MR-ample runway across ultrasound and PET. (Attach rate discussion & Figure 3, pp.18-19.)

What's Driving the Numbers

Reimbursement pull: The U.S. continues to dominate-about 9-to-1 versus Canada-thanks to CMS NTAP renewals (stroke AI) and the emerging CPT stack for CT-FFR, echo strain and breast-AI.
Enterprise buying power: Large U.S. IDNs lock multi-year "AI-store" licenses, scaling spend faster than underlying scan growth.
Regulatory clarity: FDA's Predetermined Change-Control Plan draft allows algorithm upgrades without re-filing, shortening refresh cycles and feeding ARR.
Canada's catch-up: Single-payer provinces move more cautiously, but national lung-cancer screening pilots and CADTH's positive HTA for TB AI push adoption. The lower 29 % CAGR still doubles market size every three years.
Cross-border vendors: U.S. cloud-AI providers increasingly win Canadian tenders once privacy compliance (PIPEDA/HIPAA) is proven, further narrowing the gap.

Report Benefits

Where to play / how to win: NA GTM Growth & Maturity Matrix, competitive dataset, regulatory velocity, and M&A watchlist. (Figures & tables, pp.15-18.)
Country playbooks: U.S. & Canada GTM radars, channel/pricing matrices, customer tier potential, and timelines with 12 month action cues. (U.S. pp.31-38; Canada pp.52-54.)
Forecast depth: Breakouts by country, modality, clinical area, application, revenue stream, and end use through 2032. (Tables across pp.24-30, 43-51.)

SECTION 1 - EXECUTIVE SUMMARY

25 second Read
Size & Trajectory
Modality & Attach rate Dynamics
Buyer & Route to Market
Competitive Temperature
What to do in the Next 12 Months

SECTION 2 - RESEARCH METHODOLOGY

Objective & Scope
Dual lens Architecture
North America-specific Evidence Stack & Weights
Calibration Choices (NA)

SECTION 3 - NORTH AMERICAN MARKET

Market Summary
- Market Size & Drivers
- Latest Trends
- Strategic Outlook
- Competitive Environment
- New Focus Areas
North American Market Estimates & Forecasts (2023-2032)
- AI Imaging Market by Country - North America
- What's Driving the Numbers
- Implications
Markintel GTM Growth and Maturity Matrix - North America
- Competitive Dataset - North America
- Competitive Context - North America AI-Imaging 2024
- Strategic Takeaways
- Growth & Maturity Highlights - North America
- M&A Watchlist - North America Rising Stars
Regulatory Velocity - North America
OEM AI Attach-Rate by Modality
- Attach Rate Trends - North America
- Factory vs Retrofit - North America

SECTION 4 - UNITED STATES MARKET

Market Summary - United States
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
Market Overview - United States
- Demographics & Epidemiology
- Macro economics & Health Spending
- Imaging Volume & Installed Base
- Regulatory & Reimbursement Snapshot
- Healthcare Delivery & Practice Patterns
- AI Market Dynamics (Imaging)
- Competitive Landscape
- Takeaways for Vendors
US Market by Clinical Area
- Forecast by Clinical Area (2023-2032, USD Mill)
- U.S. AI-Imaging Outlook by Clinical Area (2023 -> 2032)
- Key Dynamics to Watch
- Implications for Vendors
US Market by Imaging Modality
- Forecast by Modality (2023-2032, USD Mill)
- U.S. Modality Outlook: Who Grows, Who Overtakes
- Key Takeaways
US Market by Revenue Stream
- Forecast by Revenue Stream (2023-2032, USD Mill)
- U.S. Revenue Stream Shift: From Capital Boxes to Recurring Bytes
- What's Driving the Mix Change
- Implications for Vendors
US Market by Clinical Application
- Forecast by Clinical Application (2023-2032, USD Mill)
- Outlook by Clinical Application
- Highlights
- Implications
US Market by End-Use Organization
- Forecast by End-Use Organization (2023-2032, USD Mill)
- Who Buys AI-and How That Mix Shifts Through 2032
- What's Behind the Shift
- Strategic Implications for Vendors
US Market by AI Technology
- Forecast by AI Technology (2023-2032, USD Mill)
- Outlook by Core Technology (2023-2032)
Markintel Growth Maturity Matrix - US & Canada
- Competitive Dataset - United States
- Competitive Context - U.S./North America
- What to Watch Next
Markintel Solution Adoption & Growth Matrix - US & Canada
- Scorecard - Solution Adoption & Growth Matrix (U.S. & Canada)
- Strategic Implications for Stakeholders
Markintel Ecosystem Collaboration Matrix - US & Canada
- Who to Partner with and How Deep?
- What Succeess Looks Like in Each Quadrant
- Stratregic Guidance
GTM at a Glance - United States
- Channel & Pricing Matrix
- GTM Readiness Radar - US
- Customer Tier Potential - US
- GTM Timeline (2025-2028) - US
- Fast Strategic Cues (2025)
- Regulatory x Funding Heatmap - US
- Adjacency-Opportunity Radar - US
- Whitespace Partner-Fit Matrix - US

SECTION 5 - CANADIAN MARKET

Market Summary: Canada
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
Market Overview - Canada
- Demographics & Epidemiology
- Imaging Supply & Utilization
- Health System & Practice Patterns
- Regulatory & Reimbursement
- AI-Imaging Market Dynamics
- Competitive Snapshot
- Key Implications
Canadian Market by Clinical Area
- Forecast by Clinical Area (2023-2032, USD Mill)
- Outlook by Clinical Area
- Key Dynamics to Watch
- Implications for Vendors
Canadian Market by Imaging Modality
- Forecast by Imaging Modality (2023-2032, USD Mill)
- Outlook by Modality
- Key Dynamics to Watch (2025-27)
- Implications for Vendors
Canadian Market by Revenue Stream
- Forecast by Revenue Stream (2023-2032, USD Mill)
- What's Driving Each Revenue Stream
- Key Dynamics to Watch
- Implications for Vendors
Canadian Market by Clinical Application
- Forecast by Clinical Application (2023-2032, USD Mill)
- Outlook & Drivers by Application
- Key Market Dynamics to 2027
- Implications for Vendors and Providers
Canadian Market by End-Use Organization
- Forecast by End-Use Organization (2023-2032, USD Mill)
- Outlook 2025-2032
- Key Drivers by Segment
- Implications for Vendors
- Strategic Takeaways
Canadian Market by AI Technology
- Forecast by AI Technology (2023-2032, USD Mill)
- Highlights by Technology
- Key Dynamics to Watch (2025 27)
- Implications for Vendors & Providers
GTM at a Glance - Canada
- GTM Readiness Radar - Canada
- Tiered Customer Landscape
- Channel & Pricing Matrix
- GTM Timeline (Canada)
- Fast Cues for 2025 Stakeholders